Short interest in Franklin Genomic Advancements ETF (BATS:HELX) decreased during the last reporting period, falling from 2.05K to 367.00. This put -% of the company's publicly available shares short.

Based on the recent average volume of 11.49K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.